middle.news
Invex Therapeutics Cuts Losses Sharply, Advances Alzheimer’s Drug Research
5:22pm on Sunday 1st of June, 2025 AEST
•
Biopharmaceutical
Read Story
Invex Therapeutics Cuts Losses Sharply, Advances Alzheimer’s Drug Research
5:22pm on Sunday 1st of June, 2025 AEST
Key Points
Net loss narrowed to $356,535 from $2.1 million year-on-year
Entered research collaboration with Tessara Therapeutics on Alzheimer’s Disease
Exenatide showed protective effects in 3D human brain tissue models
Cash reserves remain strong at $5.8 million
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
IXC
OPEN ARTICLE